Clinical Trials

May 5, 2018

Durham med device startup Camras Vision eyes more capital to boost growth

DURHAM — Camras Vision Inc, a glaucoma treatment device startup that just completed funding of $5.7 million, will be seeking a Series B funding in 2019 of approximately $15 million. The…